PRO DEX INC PDEX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
8.16
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $66.6M | $9.0M | $19.5M | — | $36.6M |
| 2024 | $53.8M | $2.1M | $14.6M | — | $30.9M |
| 2023 | $46.1M | $7.1M | $12.7M | — | $31.6M |
| 2022 | $42.0M | $4.6M | $13.1M | -$2.5M | $25.4M |
| 2021 | $38.0M | $6.2M | $13.6M | -$3.8M | $21.1M |
| 2020 | $34.8M | $6.1M | $13.1M | $4.4M | $19.1M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 8.16 (safe)
- Working capital / assets 0.534
- Retained earnings / assets 0.587
- EBIT / assets 0.175
- Equity / liabilities 1.492
Source: SEC EDGAR filings · CIK 0000788920 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.